Aktuellt
SENASTE
Redeye provides an update following Heliospectra’s Q1’23 report, where an increased gross margin, a well-controlled cost basis, and management’s anticipation of robust order intake in Q2’23 support an optimistic outlook. Sales and order intake came in slightly lower than expected. Hence, we have made a few minor changes to our near-term estimates. Our fair value range, however, remains unchanged, with a base case of SEK1.9 per share.
LÄS MER
